NCT05237648

Brief Summary

The purpose of this study is to assess the effects of incorporating educational online modules into voice therapy. One of the main reasons that voice therapy fails is lack of participation and engagement from the patient's side. The researchers hope to learn if increasing patient engagement via educational online modules during this waiting period between evaluation and first therapy session is useful in increasing understanding of the therapeutic framework of voice therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

January 19, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2024

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

1.8 years

First QC Date

January 21, 2022

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of voice handicap perception across the 3 groups

    Will be measured by Voice Handicap Index -10 (VHI-10), a patient reported outcome measure used to record the patient's perception of impairment or handicap due to a voice problem. A score of over 10 is considered to be abnormal. The scores in all three groups will be compared and analyzed.

    Baseline (Day 1) visit, 8 - 10 week visit

  • Change of Online education module acceptance across the 3 groups

    Will be measured by attendance data (number of sessions recommended versus attended, number of no shows) using the standard patient data collected according to standard of care process.

    Baseline Visit (Day 1), Last day of visit (up to 4 months from baseline)

Secondary Outcomes (3)

  • Change of perceived effectiveness of voice therapy

    Baseline (Day 1) visit, 8 - 10 week visit

  • Change of patient's perception on voice therapy

    Baseline (Day 1) visit, 8 - 10 week visit

  • Change of perceptual voice ratings

    Baseline (Day 1) visit, 8 - 10 week visit

Study Arms (3)

Experimental Group

EXPERIMENTAL

Participants will complete an online module with content focusing on patient self-rating of vocal quality within 24 hours of evaluation, approximately 1-2 weeks prior to their first therapy session, and within 24 hours after each therapy session;

Other: Online Voice quality education module

Sham Control Group

SHAM COMPARATOR

Participants will complete an online module within 24 hours of evaluation, approximately 1-2 weeks prior to their first therapy session, and within 24 hours after each therapy session with content focusing on vocal hygiene.

Other: Vocal hygiene module

Control group

NO INTERVENTION

Participants will not complete an online module. The groups will be compared in terms of attendance, self-efficacy, and treatment outcome measures based on the data collected within the NYU Voice Center standard of care

Interventions

The novel online module the authors developed consists of a patient education on acoustic-perceptual rating of voice quality (CAPE-V), practice rating sample recordings of others' voices, and the patient's self-rating of their own voice in real time during a standard sentence-reading task. The module also includes the Self-Efficacy Scale for Voice Therapy.

Experimental Group

The generic online patient education module on vocal hygiene during the waiting period between their initial evaluation and their first therapy session that also includes the Self-Efficacy Scale for Voice Therapy

Sham Control Group

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 years
  • English-speaking
  • Have access to technology, including Internet
  • Diagnosed with dysphonia with a recommended treatment of voice therapy.
  • Willingness to complete all clinical/research assessments
  • Ability to give informed consent

You may not qualify if:

  • Patients who undergo surgical intervention during the course of therapy Contraindications for participation in voice therapy
  • Diagnosis of Parkinson's Disease or other neurodegenerative, progressive disorder (e.g., ALS)
  • Previous training in acoustic-perceptual voice quality rating, for example a speech language pathology student
  • Visual impairments that would prevent the completion of an online module.
  • Those with self-reported moderate-profound hearing loss or deafness that would preclude them from participating in the study
  • Inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Dysphonia

Condition Hierarchy (Ancestors)

Voice DisordersLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Aaron Johnson, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2022

First Posted

February 14, 2022

Study Start

January 19, 2023

Primary Completion

October 22, 2024

Study Completion

October 22, 2024

Last Updated

November 28, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices)

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data.Upon reasonable request. Requests should be directed to Aaron.Johnson@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.

Locations